Mirabegron For Erectile Dysfunction

Summary

The only class of oral erectile dysfunction (ED) medication on the market are the phosphodiesterase Type 5 inhibitors (PDE5i). This pilot study is being done to evaluate the effect of Mirabegron, an oral beta-3 adrenergic agonist, on men with both Overactive Bladder (OAB) symptoms and mild to moderate ED.

Timeline

Start

2017-08-01

Primary completion

2020-01-01

Completion

2020-01-01

Drugs

Indications